DJ.Σn

I compared prescription peptides to research peptides. Here is what I noticed after testing both:

Eli Lilly released retatrutide Phase 3 data yesterday. 28% weight loss in 80 weeks. The most powerful obesity drug that’s ever been tested. And today the cancer signal drops. 12,112 patients. Seven tumor types. GLP-1 users had half the lung cancer metastasis rate (10% vs 22%). Breast cancer: 43% cut. Colon cancer five-year mortality in a separate study: 15.5% vs 37.1%. Cancer joins a list that already includes heart disease (SELECT, 20% MACE reduction), kidney failure (FLOW, 24% slower decline), sleep apnea (SURMOUNT-OSA, FDA-approved), addiction (BMJ, 600K veterans, 18-25% reduction across substances), and liver disease (86% fat clearance). Tumors express GLP-1 receptors. Activate them and NF-kB drops, apoptosis rises. The drug isn’t just shrinking fat. It’s talking directly to the cancer. One drug class. Designed for blood sugar. The biology keeps finding uses the designers didn’t predict.

Willingly choosing to gamble on Spartans is a simple iq test. Gurhan Kiziloz’s other project Blockdag Network pivoted to a casino recently after not shipping mainnet or miners for years (still claiming you’ll profit 300X via presale). Meanwhile he extracted at least $350M from unsophisticated retail investors while spending lots on cars, watches real estate. My current theory is his casino may have been used to help legitimize Blockdag funds hence overpaying employees/ KOLs.

starts with P and we all love it?